Page last updated: 2024-09-02

fingolimod hydrochloride and Cherry Red Spot Myoclonus Syndrome

fingolimod hydrochloride has been researched along with Cherry Red Spot Myoclonus Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, SM; DeRosa, SG; Ferreira, NS; Furness, AM; Futerman, AH; Gao, D; Grishchuk, Y; Herron, SS; Medina, DL; Mepyans, ME; Sankar, SB; Scotto Rosato, A; Slaugenhaupt, SA; Smith, SS; Vardi, A; Weinstock, LD; Wood, LB	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Cherry Red Spot Myoclonus Syndrome

Article	Year
Fingolimod phosphate inhibits astrocyte inflammatory activity in mucolipidosis IV. Human molecular genetics, 2018, 08-01, Volume: 27, Issue:15 Topics: Animals; Astrocytes; Brain; Cells, Cultured; Cytokines; Disease Models, Animal; Encephalitis; Female; Fingolimod Hydrochloride; Gene Expression Regulation; Lysosomal Membrane Proteins; Male; Mice, Knockout; Mucolipidoses; Phosphatidylinositol 3-Kinases; Phosphoproteins; Proto-Oncogene Proteins c-akt; Transient Receptor Potential Channels	2018

Article

Year

Fingolimod phosphate inhibits astrocyte inflammatory activity in mucolipidosis IV.

Human molecular genetics, 2018, 08-01, Volume: 27, Issue:15

Topics: Animals; Astrocytes; Brain; Cells, Cultured; Cytokines; Disease Models, Animal; Encephalitis; Female; Fingolimod Hydrochloride; Gene Expression Regulation; Lysosomal Membrane Proteins; Male; Mice, Knockout; Mucolipidoses; Phosphatidylinositol 3-Kinases; Phosphoproteins; Proto-Oncogene Proteins c-akt; Transient Receptor Potential Channels

2018